Biomaterial Database

[A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid]. 1989

G Ludera-Zimoch, and J Rubisz-Brzezińska

In 55-year-old woman with a history of 19 years of superficial disseminated actinic porokeratosis Tigason was used in doses from 0.7 to 0.5 mg/kg daily in two courses of therapy lasting about 3 months. The clinical improvement lasted for several months and their followed by less pronounced but progressive reappearance of clinical symptoms.

UI	MeSH Term	Description	Entries
D007642	Keratosis	Any horny growth such as a wart or callus.	Keratoderma Blennorrhagicum,Keratoma,Keratosis Blennorrhagica,Blennorrhagica, Keratosis,Blennorrhagicas, Keratosis,Blennorrhagicum, Keratoderma,Blennorrhagicums, Keratoderma,Keratoderma Blennorrhagicums,Keratomas,Keratoses,Keratosis Blennorrhagicas
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D010241	Parakeratosis	Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. (Dorland, 27th ed)	Parakeratoses
D005050	Etretinate	An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.	B10-9359,Ethyl Etrinoate,Ro 10-9359,Ro-10-9359,Tigason,Tigazon,B10 9359,B109359,Etrinoate, Ethyl,Ro 10 9359,Ro 109359,Ro109359
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man